• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗癌硒代氨基脲的优势:其铁(III)、铜(II)和锌(II)配合物与关键生理还原剂/配体相比同构硫代氨基脲的优先反应性。

Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isosteric Thiosemicarbazones.

作者信息

Dharmasivam Mahendiran, Zhang Stanley, Zhao Xiao, Richardson Vera, Wijesinghe Tharushi P, Suleymanoglu Mediha, Gholam Azad Mahan, Bernhardt Paul V, Kaya Busra, Richardson Des R

机构信息

Centre for Cancer Cell Biology and Drug Discovery, Institute for Biomedicine and Glycomics, Griffith University, Southport 4215 Queensland, Australia.

Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34093, Turkey.

出版信息

J Med Chem. 2025 May 8;68(9):9594-9622. doi: 10.1021/acs.jmedchem.5c00374. Epub 2025 Apr 23.

DOI:10.1021/acs.jmedchem.5c00374
PMID:40265585
Abstract

Fe(III) complexes of clinically trialed thiosemicarbazones demonstrate deleterious oxy-myoglobin and oxy-hemoglobin oxidation. Therefore, the PPP4pSe selenosemicarbazone analogues were designed with several PPP4pSe Fe(III) complexes completely preventing deleterious oxy-myoglobin oxidation. This was ascribed to the decreased potentials of their Fe(III) complexes and steric hindrance effects. The Fe(III), Cu(II), and Zn(II) complexes of PPP4pSe demonstrated greater reactivity with physiological reductants/ligands (glutathione, l-cysteine, or l-ascorbate), than respective complexes of the isosteric thiosemicarbazone, PPP4pT. Considering this: (1) [Fe(PPP4pSe)] demonstrated increased reduction relative to [Fe(PPP4pT)] with glutathione and l-cysteine, while l-ascorbate led to comparable reduction; (2) glutathione led to complete dissociation of [Zn(PPP4pSe)], while incomplete dissociation of [Zn(PPP4pT)] occurred; and (3) [Cu(PPP4pSe)Cl] demonstrated complete coordinate sphere substitution with glutathione, l-cysteine, and l-ascorbate, whereas [Cu(PPP4pT)Cl] demonstrated partial substitution. The role of glutathione in all three latter reactions is significant, given the greater reactivity of the selenosemicarbazone, and glutathione's key role in selenosemicarbazone and thiosemicarbazone anticancer activity.

摘要

临床试用的硫代半卡巴腙的铁(III)配合物表现出有害的氧合肌红蛋白和氧合血红蛋白氧化。因此,设计了PPP4pSe硒代半卡巴腙类似物,其几种PPP4pSe铁(III)配合物能完全防止有害的氧合肌红蛋白氧化。这归因于其铁(III)配合物电位的降低和空间位阻效应。PPP4pSe的铁(III)、铜(II)和锌(II)配合物与生理还原剂/配体(谷胱甘肽、L-半胱氨酸或L-抗坏血酸)的反应性比等排硫代半卡巴腙PPP4pT的相应配合物更高。考虑到这一点:(1)相对于[Fe(PPP4pT)],[Fe(PPP4pSe)]与谷胱甘肽和L-半胱氨酸反应时还原增加,而L-抗坏血酸导致的还原相当;(2)谷胱甘肽导致[Zn(PPP4pSe)]完全解离,而[Zn(PPP4pT)]发生不完全解离;(3)[Cu(PPP4pSe)Cl]与谷胱甘肽、L-半胱氨酸和L-抗坏血酸反应时表现出完全的配位球取代,而[Cu(PPP4pT)Cl]表现出部分取代。鉴于硒代半卡巴腙的更高反应性以及谷胱甘肽在硒代半卡巴腙和硫代半卡巴腙抗癌活性中的关键作用,谷胱甘肽在上述后三个反应中的作用很重要。

相似文献

1
Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isosteric Thiosemicarbazones.新型抗癌硒代氨基脲的优势:其铁(III)、铜(II)和锌(II)配合物与关键生理还原剂/配体相比同构硫代氨基脲的优先反应性。
J Med Chem. 2025 May 8;68(9):9594-9622. doi: 10.1021/acs.jmedchem.5c00374. Epub 2025 Apr 23.
2
Steric Blockade of Oxy-Myoglobin Oxidation by Thiosemicarbazones: Structure-Activity Relationships of the Novel PPP4pT Series.氧合肌红蛋白氧化的立体位阻阻断:新型 PPP4pT 系列的结构-活性关系。
J Med Chem. 2023 Nov 23;66(22):15453-15476. doi: 10.1021/acs.jmedchem.3c01612. Epub 2023 Nov 3.
3
Innovative -Acridine Thiosemicarbazones and Their Zn(II) Complexes Transmetallate with Cu(II): Redox Activity and Suppression of Detrimental Oxy-Myoglobin Oxidation.创新的吖啶硫代脒及其 Zn(II) 配合物与 Cu(II) 发生转移金属化:氧化还原活性和抑制有害氧肌红蛋白氧化。
Inorg Chem. 2024 Oct 28;63(43):20840-20858. doi: 10.1021/acs.inorgchem.4c03642. Epub 2024 Oct 15.
4
Isosteric Replacement of Sulfur to Selenium in a Thiosemicarbazone: Promotion of Zn(II) Complex Dissociation and Transmetalation to Augment Anticancer Efficacy.硫代氨基脲中硫到硒的等排取代:促进锌(II)配合物解离和金属转移以增强抗癌疗效。
J Med Chem. 2024 Jul 25;67(14):12155-12183. doi: 10.1021/acs.jmedchem.4c00884. Epub 2024 Jul 5.
5
Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.铜和锌双(硫代缩氨基甲酸盐)配合物的合成、表征及体外抗癌活性。
Inorg Chem. 2019 Oct 21;58(20):13709-13723. doi: 10.1021/acs.inorgchem.9b01281. Epub 2019 Jul 24.
6
Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.具有强效和选择性抗肿瘤活性的烷基取代 2'-苯甲酰基吡啶硫代半卡巴腙螯合剂:限制高铁血红蛋白形成的新型配体。
J Med Chem. 2013 Jan 10;56(1):357-70. doi: 10.1021/jm301691s. Epub 2012 Dec 31.
7
Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.新型 ApT 和 DpT 系列硫代卡巴腙及其铜配合物:显著氧化还原活性的鉴定及其抗肿瘤活性的表征。
J Med Chem. 2010 Aug 12;53(15):5759-69. doi: 10.1021/jm100561b.
8
2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.2-乙酰基吡啶硫代半卡巴腙是有效的铁螯合剂和抗增殖剂:氧化还原活性、铁络合及其抗肿瘤活性的表征。
J Med Chem. 2009 Mar 12;52(5):1459-70. doi: 10.1021/jm801585u.
9
Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.新型铁螯合剂的设计、合成与表征:2-苯甲酰基吡啶硫代半卡巴腙系列及其3-硝基苯甲酰类似物作为强效抗肿瘤剂的构效关系
J Med Chem. 2007 Jul 26;50(15):3716-29. doi: 10.1021/jm070445z. Epub 2007 Jun 30.
10
Novel Copper(II) Coordination Compounds Containing Pyridine Derivatives of -Methoxyphenyl-Thiosemicarbazones with Selective Anticancer Activity.含有α-甲氧基苯基硫代氨基脲吡啶衍生物的新型具有选择性抗癌活性的铜(II)配位化合物。
Molecules. 2024 Dec 19;29(24):6002. doi: 10.3390/molecules29246002.

引用本文的文献

1
Thiosemicarbazone-Based Compounds: Cancer Cell Inhibitors with Antioxidant Properties.基于硫代卡巴腙的化合物:具有抗氧化特性的癌细胞抑制剂。
Molecules. 2025 May 7;30(9):2077. doi: 10.3390/molecules30092077.